|
RPP38 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.930000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.593800E-01 |
| Normal-vs-Stage2 |
9.472400E-01 |
| Normal-vs-Stage3 |
1.934840E-01 |
| Normal-vs-Stage4 |
2.130800E-01 |
| Stage1-vs-Stage2 |
3.552200E-01 |
| Stage1-vs-Stage3 |
6.055700E-03 |
| Stage1-vs-Stage4 |
5.812800E-01 |
| Stage2-vs-Stage3 |
2.995200E-01 |
| Stage2-vs-Stage4 |
2.778600E-01 |
| Stage3-vs-Stage4 |
1.775760E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.816400E-01 |
| Normal-vs-AfricanAmerican |
5.555000E-03 |
| Normal-vs-Asian |
6.480400E-01 |
| Caucasian-vs-AfricanAmerican |
2.973800E-04 |
| Caucasian-vs-Asian |
7.150200E-01 |
| AfricanAmerican-vs-Asian |
1.363250E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.817200E-01 |
| Normal-vs-Female |
2.655700E-02 |
| Male-vs-Female |
4.798600E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.287400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.518200E-01 |
| Normal-vs-Age(61-80Yrs) |
5.957200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.268800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.002800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.546200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.359000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.190800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.306800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.503800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.398770E-01 |
| Normal-vs-Grade 2 |
2.085400E-01 |
| Normal-vs-Grade 3 |
5.191400E-01 |
| Normal-vs-Grade 4 |
7.794000E-01 |
| Grade 1-vs-Grade 2 |
1.235170E-01 |
| Grade 1-vs-Grade 3 |
2.396100E-02 |
| Grade 1-vs-Grade 4 |
1.515830E-01 |
| Grade 2-vs-Grade 3 |
1.387820E-02 |
| Grade 2-vs-Grade 4 |
4.818400E-01 |
| Grade 3-vs-Grade 4 |
4.370000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.244200E-02 |
| Normal-vs-ccB subtype |
2.687900E-02 |
| ccA subtype-vs-ccB subtype |
9.01639999995041E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.847600E-01 |
| Normal-vs-N1 |
1.706180E-01 |
| N0-vs-N1 |
2.596400E-01 |
|
|
